TIN Ny Teknik vs UBS Lux Equity Fund Biotech USD

TIN Ny Teknik vs UBS Lux Equity Fund Biotech USD

1. TIN Ny Teknik

  • Security

    TIN Ny Teknik A

  • Fee

    1.50%

  • ISIN

    SE0012193019

  • Holdings

    10

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 10 holdings in TIN Ny Teknik, where the largest holding is Surgical Science (7.39), followed by Novo Nordisk (5.98) and ChemoMetec (5.92). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in TIN Ny Teknik and UBS Lux Equity Fund Biotech USD.

TIN Ny Teknik UBS Lux Equity Fund Biotech USD
1. Surgical Science Sweden AB
Sweden
7.39 %		 1. Regeneron Pharmaceuticals Inc
10.04 %
2. Novo Nordisk B
Denmark
5.98 %		 2. Moderna Inc
9.21 %
3. ChemoMetec
Denmark
5.92 %		 3. Vertex Pharmaceuticals Inc
8.44 %
4. Paradox Interactive AB
Sweden
5.85 %		 4. Alnylam Pharmaceuticals Inc
8.08 %
5. Qt Group Plc
Finland
5.12 %		 5. AbbVie Inc
USA
4.91 %
6. Epidemic Sound Holdings AB
Sweden
5.11 %		 6. Gilead Sciences Inc
USA
4.66 %
7. BioGaia B
Sweden
5.06 %		 7. Amgen Inc
USA
4.43 %
8. Fortnox AB
Sweden
5.02 %		 8. BioNTech SE
4.13 %
9. Evolution Gaming Group AB
Sweden
4.6 %		 9. Karuna Therapeutics Inc
3.75 %
10. Sectra B
Sweden
4.45 %		 -

The list of fund holdings was last updated on July 28, 2025.